lncRNA Kcnq1ot1 promotes bone formation by inhibiting miR-98-5p/Tbx5 axis in MC3T3-E1 cells

Furong Wang1, Fucai Zhang1, Feng Zheng1

  • 1Department of Orthopedics, Qinghai Provincial People's Hospital, Chengdong, Xining, Qinghai 810007, P.R. China.

Insights

Long non-coding RNA KCNQ1 opposite strand/antisense transcript 1 (Kcnq1ot1) promotes bone formation by inhibiting microRNA-98-5p and upregulating T-box transcription factor 5. This pathway offers potential therapeutic targets for osteoporosis treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Background:

  • Long non-coding RNA KCNQ1 opposite strand/antisense transcript 1 (Kcnq1ot1) is implicated in various biological processes.
  • The specific role and mechanism of Kcnq1ot1 in osteoporosis remain largely unexplored.

Purpose of the Study:

  • To investigate the function of lncRNA Kcnq1ot1 in osteogenic differentiation.
  • To elucidate the molecular mechanism underlying Kcnq1ot1's role in bone formation.

Main Methods:

  • Quantitative PCR to measure Kcnq1ot1, microRNA-98-5p (miR-98-5p), and T-box transcription factor 5 (Tbx5) expression.
  • Dual luciferase reporter assays to confirm interactions between Kcnq1ot1, miR-98-5p, and Tbx5.
  • Biochemical assays (ALP activity, Alizarin red S staining) and Western blotting to assess osteogenic differentiation.

Main Results:

  • Kcnq1ot1 expression increased, while miR-98-5p decreased during osteogenic differentiation.
  • Kcnq1ot1 directly targets and inhibits miR-98-5p, which in turn regulates Tbx5 expression.
  • Kcnq1ot1 knockdown impaired osteogenic differentiation; miR-98-5p inhibition or Tbx5 downregulation reversed this effect.

Conclusions:

  • Kcnq1ot1 promotes osteogenic differentiation and bone formation by negatively regulating miR-98-5p and positively regulating Tbx5.
  • The Kcnq1ot1/miR-98-5p/Tbx5 axis represents a potential therapeutic target for osteoporosis.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.3K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
6.1K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
8.2K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.3K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.1K